Answers are grounded in this paper and cite their sources.
The approach for colorectal hepatic metastasis has advanced tremendously over the past decade. Multidrug chemotherapy regimens have been successfully introduced with improved outcomes. Concurrently, adjunct multimodal therapies have improved survival rates, and increased the number of patients eligible for curative liver resection. Herein, we described major advancements of surgical and oncologic management of such lesions, thereby discussing modern chemotherapeutic regimens, adjunct therapies and surgical aspects of liver resection.
No takes yet. Share an insight, caveat, or question.
Francisco Igor Macedo (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: